Medicine and Dentistry
Patient
100%
Systemic Lupus Erythematosus
49%
Rheumatoid Arthritis
49%
Follow up
43%
Symptom
35%
Observational Study
35%
Male
21%
Serum
18%
Woman
18%
Antiphospholipid Antibody
17%
Cells
16%
Pregnancy
16%
Syndrome
16%
Cytotechnology
16%
Child
16%
Drug
16%
Intima-Media Thickness
16%
Granulocyte
16%
Serositis
16%
Common Carotid Artery
16%
COVID-19
16%
Crithidia
16%
Methotrexate
10%
Echocardiography
9%
Cytoplasm
8%
Hazard Ratio
8%
Spontaneous Remission
7%
Age
7%
Atherosclerosis
6%
Diagnostic Accuracy
6%
Female
5%
Lupus Nephritis
5%
Rheumatology
5%
Epileptic Absence
5%
Immunology and Microbiology
Inflammatory Arthritis
49%
Phospholipid Antibody
17%
Complement Component C3d
16%
Crithidia Luciliae
16%
Umbilical Cord Blood
16%
TNF Inhibitor
16%
Complement System
13%
Complement Component C1q
8%
Inflammation
6%
Lupus Erythematosus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor Inhibitor
32%
Tolerability
19%
Psoriatic Arthritis
16%
Rheumatoid Arthritis
16%
Inflammatory Arthritis
16%
Antibodies
8%